TF Financial (THRD) Competitors

TF Financial (NASDAQ:THRD) and Collegium Pharmaceutical (NASDAQ:COLL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership.

Do analysts rate THRD or COLL?

TF Financial presently has a consensus target price of $5.00, suggesting a potential downside of 7.92%. Collegium Pharmaceutical has a consensus target price of $43.75, suggesting a potential upside of 49.93%. Given Collegium Pharmaceutical's stronger consensus rating and higher probable upside, analysts clearly believe Collegium Pharmaceutical is more favorable than TF Financial.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TF Financial	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Collegium Pharmaceutical	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Which has preferable earnings and valuation, THRD or COLL?

Collegium Pharmaceutical has higher revenue and earnings than TF Financial. TF Financial is trading at a lower price-to-earnings ratio than Collegium Pharmaceutical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TF Financial	N/A	N/A	-$30.82M	-$0.62	-8.76
Collegium Pharmaceutical	$664.28M	1.41	$48.15M	$1.22	23.92

Which has more volatility and risk, THRD or COLL?

TF Financial has a beta of 2.66, indicating that its share price is 166% more volatile than the S&P 500. Comparatively, Collegium Pharmaceutical has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.

Does the MarketBeat Community favor THRD or COLL?

Collegium Pharmaceutical received 330 more outperform votes than TF Financial when rated by MarketBeat users. However, 65.59% of users gave TF Financial an outperform vote while only 65.38% of users gave Collegium Pharmaceutical an outperform vote.

Company	Underperform	Outperform
TF Financial	Outperform Votes 61 65.59%	Underperform Votes 32 34.41%
Collegium Pharmaceutical	Outperform Votes 391 65.38%	Underperform Votes 207 34.62%

Do insiders and institutionals hold more shares of THRD or COLL?

94.0% of TF Financial shares are held by institutional investors. 5.9% of TF Financial shares are held by company insiders. Comparatively, 2.5% of Collegium Pharmaceutical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is THRD or COLL more profitable?

Collegium Pharmaceutical has a net margin of 14.78% compared to TF Financial's net margin of 0.00%. Collegium Pharmaceutical's return on equity of 104.67% beat TF Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TF Financial	N/A	-9.31%	-9.03%
Collegium Pharmaceutical	14.78%	104.67%	18.38%

Does the media prefer THRD or COLL?

In the previous week, Collegium Pharmaceutical had 3 more articles in the media than TF Financial. MarketBeat recorded 6 mentions for Collegium Pharmaceutical and 3 mentions for TF Financial. Collegium Pharmaceutical's average media sentiment score of 0.78 beat TF Financial's score of 0.00 indicating that Collegium Pharmaceutical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TF Financial	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Collegium Pharmaceutical	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Collegium Pharmaceutical beats TF Financial on 13 of the 17 factors compared between the two stocks.